Compare Stocks: NNOX, ELMD, STIM, and PROF

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ELMD Electromed	$27.57	$35.33	$23.01 ▼ $47.40	$230.65M	0.46	78,443 shs	71,815 shs
NNOX Nano-X Imaging	$0.70 -4.7%	$0.89	$0.67 ▼ $4.71	$57.52M	1.26	1.42 million shs	1.05 million shs
PROF Profound Medical	$5.74 -2.5%	$6.83	$4.80 ▼ $8.95	$215.18M	0.72	116,311 shs	82,165 shs
STIM Neuronetics	$2.88 -1.0%	$2.62	$0.80 ▼ $3.44	$221.73M	1.16	1.25 million shs	779,699 shs

The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ELMD Electromed	+2.11%	+4.87%	-30.11%	-29.52%	+10.86%
NNOX Nano-X Imaging	-0.73%	+6.07%	-14.89%	-53.38%	-81.79%
PROF Profound Medical	-3.44%	+3.70%	-13.25%	-9.52%	+36.98%
STIM Neuronetics	+2.11%	+3.93%	-3.00%	+130.95%	+2.46%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ELMD Electromed	$27.57	$35.33	$23.01 ▼ $47.40	$230.65M	0.46	78,443 shs	71,815 shs
NNOX Nano-X Imaging	$0.70 -4.7%	$0.89	$0.67 ▼ $4.71	$57.52M	1.26	1.42 million shs	1.05 million shs
PROF Profound Medical	$5.74 -2.5%	$6.83	$4.80 ▼ $8.95	$215.18M	0.72	116,311 shs	82,165 shs
STIM Neuronetics	$2.88 -1.0%	$2.62	$0.80 ▼ $3.44	$221.73M	1.16	1.25 million shs	779,699 shs

The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ELMD Electromed	+2.11%	+4.87%	-30.11%	-29.52%	+10.86%
NNOX Nano-X Imaging	-0.73%	+6.07%	-14.89%	-53.38%	-81.79%
PROF Profound Medical	-3.44%	+3.70%	-13.25%	-9.52%	+36.98%
STIM Neuronetics	+2.11%	+3.93%	-3.00%	+130.95%	+2.46%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ELMD Electromed	2.75	Moderate Buy	$43.75	58.69% Upside
NNOX Nano-X Imaging	2.50	Moderate Buy	$4.33	521.00% Upside
PROF Profound Medical	2.67	Moderate Buy	$11.50	100.35% Upside
STIM Neuronetics	2.60	Moderate Buy	$4.67	62.04% Upside

Current Analyst Ratings Breakdown

Latest NNOX, ELMD, STIM, and PROF Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/17/2026	STIM Neuronetics	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$6.00
9/14/2026	STIM Neuronetics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
9/11/2026	STIM Neuronetics	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy
9/11/2026	STIM Neuronetics	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$5.00
9/9/2026	STIM Neuronetics	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$6.00
8/26/2026	ELMD Electromed	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$50.00
8/26/2026	ELMD Electromed	Lake Street Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$36.00 ➝ $47.00
8/17/2026	NNOX Nano-X Imaging	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Overweight	$5.00
8/12/2026	PROF Profound Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/11/2026	STIM Neuronetics	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$5.00 ➝ $6.00
7/29/2026	PROF Profound Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)

(Data available from 9/23/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ELMD Electromed	$73.78M	3.13	$0.67 per share	41.36	$5.10 per share	5.41
NNOX Nano-X Imaging	$13.02M	4.21	N/A	N/A	$2.01 per share	0.35
PROF Profound Medical	$16.10M	13.02	N/A	N/A	$1.83 per share	3.14
STIM Neuronetics	$149.16M	1.47	N/A	N/A	$0.38 per share	7.58

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ELMD Electromed	$5.15M	$1.31	36.76	N/A	N/A	11.34%	15.71%	13.37%	N/A
NNOX Nano-X Imaging	-$75.02M	-$2.14	N/A	N/A	N/A	-926.05%	-116.93%	-100.67%	11/19/2026 (Estimated)
PROF Profound Medical	-$42.57M	-$0.98	N/A	N/A	N/A	-171.57%	-63.03%	-51.24%	11/12/2026 (Estimated)
STIM Neuronetics	-$39M	-$0.44	N/A	N/A	N/A	-19.62%	-125.11%	-22.15%	11/3/2026 (Estimated)

Latest NNOX, ELMD, STIM, and PROF Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
9/9/2026	Q2 2026	NNOX Nano-X Imaging	-$0.1620	-$0.79	-$0.6280	-$0.79	$5.38 million	$4.16 million
8/11/2026	Q2 2026	STIM Neuronetics	-$0.1230	-$0.05	+$0.0730	-$0.05	$40.17 million	$41.57 million
8/6/2026	Q2 2026	PROF Profound Medical	-$0.22	-$0.26	-$0.04	$0.26	$4.75 million	$2.48 million
6/25/2026	Q1 2026	NNOX Nano-X Imaging	N/A	-$0.16	N/A	-$0.20	N/A	$4.31 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ELMD Electromed	N/A	N/A	N/A	N/A	N/A
NNOX Nano-X Imaging	N/A	N/A	N/A	N/A	N/A
PROF Profound Medical	N/A	N/A	N/A	N/A	N/A
STIM Neuronetics	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ELMD Electromed	N/A	5.10	4.74
NNOX Nano-X Imaging	N/A	2.84	2.59
PROF Profound Medical	N/A	6.46	5.31
STIM Neuronetics	2.84	1.88	1.69

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ELMD Electromed	40.82%
NNOX Nano-X Imaging	21.49%
PROF Profound Medical	47.86%
STIM Neuronetics	53.59%

Insider Ownership

Company	Insider Ownership
ELMD Electromed	10.50%
NNOX Nano-X Imaging	7.74%
PROF Profound Medical	1.52%
STIM Neuronetics	8.40%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ELMD Electromed	197	8.37 million	7.36 million	Optionable
NNOX Nano-X Imaging	197	78.59 million	72.51 million	Optionable
PROF Profound Medical	162	36.53 million	35.98 million	Optionable
STIM Neuronetics	658	76.20 million	69.80 million	Optionable

NNOX, ELMD, STIM, and PROF Headlines

Recent News About These Companies

Neuronetics stock holds after August 11 earnings beat

September 19, 2026 | ad-hoc-news.deA

BTIG Research Reiterates Buy Rating for Neuronetics (NASDAQ:STIM)

September 17, 2026 | marketbeat.com

Analysts Set Neuronetics, Inc. (NASDAQ:STIM) PT at $4.50

September 16, 2026 | americanbankingnews.com

Neuronetics (NASDAQ:STIM) Coverage Initiated at B. Riley Financial

September 13, 2026 | americanbankingnews.com

B Riley Securities initiates coverage of Neuronetics at buy

September 12, 2026 | msn.com

B. Riley Initiates Neuronetics at Buy With $5 Price Target

September 11, 2026 | marketscreener.comM

Neuronetics (NASDAQ:STIM) Now Covered by B. Riley Financial

September 11, 2026 | marketbeat.com

Neuronetics, Inc. (NASDAQ:STIM) Receives Average Recommendation of "Moderate Buy" from Brokerages

September 11, 2026 | marketbeat.com

BTIG Research Reaffirms "Buy" Rating for Neuronetics (NASDAQ:STIM)

September 9, 2026 | marketbeat.com

NeuroStar Advances Practice Innovation with First-Ever TMS Integration with an EHR/EMR System

September 8, 2026 | globenewswire.com

BlackRock Inc. Invests $776,000 in Neuronetics, Inc. $STIM

September 7, 2026 | marketbeat.com

18,540,488 Shares in Neuronetics, Inc. $STIM Purchased by Madryn Asset Management LP

August 29, 2026 | marketbeat.com

Neuronetics (STIM) Q2 2026 Earnings Call Transcript

August 18, 2026 | finance.yahoo.com

Neuronetics (NASDAQ:STIM) Major Shareholder Acquires 14,000 Shares of Stock

August 18, 2026 | insidertrades.com

Neuronetics, Inc. (STIM) Q2 FY2026 earnings call transcript

August 12, 2026 | finance.yahoo.com

Neuronetics Inc (STIM) (Q2 2026) Earnings Call Highlights: Revenue Growth and Margin Expansion ...

August 12, 2026 | finance.yahoo.com

Neuronetics: Q2 Earnings Snapshot

August 11, 2026 | wtop.comW

Neuronetics Reports Second Quarter 2026 Financial and Operating Results

August 11, 2026 | markets.businessinsider.com

Neuronetics, Inc. (STIM) Q2 2026 Earnings Call Transcript

August 11, 2026 | seekingalpha.com

Neuronetics narrows Q2 loss as Greenbrook growth drives 9% revenue increase

August 11, 2026 | msn.com

Neuronetics (STIM) Reports Q2 Loss, Beats Revenue Estimates

August 11, 2026 | zacks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

NNOX, ELMD, STIM, and PROF Company Descriptions

Electromed NYSE:ELMD

$27.57 0.00 (0.00%)

Closing price 04:00 PM Eastern

Extended Trading

$27.64 +0.07 (+0.24%)

As of 07:30 PM Eastern

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products to hospitals, home health care centers, pulmonary rehabilitation centers, cystic fibrosis centers, neuromuscular clinics, and other clinics through distributors. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.

Nano-X Imaging NASDAQ:NNOX

$0.70 -0.03 (-4.66%)

Closing price 04:00 PM Eastern

Extended Trading

$0.70 +0.00 (+0.60%)

As of 07:50 PM Eastern

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source, and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company is headquartered in Petach Tikva, Israel.

Profound Medical NASDAQ:PROF

$5.74 -0.15 (-2.55%)

Closing price 04:00 PM Eastern

Extended Trading

$5.74 0.00 (-0.09%)

As of 04:10 PM Eastern

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada.

Neuronetics NASDAQ:STIM

$2.88 -0.03 (-1.03%)

Closing price 04:00 PM Eastern

Extended Trading

$2.88 +0.00 (+0.17%)

As of 07:30 PM Eastern

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest NNOX, ELMD, STIM, and PROF Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest NNOX, ELMD, STIM, and PROF Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

NNOX, ELMD, STIM, and PROF Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

NNOX, ELMD, STIM, and PROF Company Descriptions

Electromed NYSE:ELMD

Nano-X Imaging NASDAQ:NNOX

Profound Medical NASDAQ:PROF

Neuronetics NASDAQ:STIM

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest NNOX, ELMD, STIM, and PROF Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest NNOX, ELMD, STIM, and PROF Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

NNOX, ELMD, STIM, and PROF Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

NNOX, ELMD, STIM, and PROF Company Descriptions

Electromed NYSE:ELMD

Nano-X Imaging NASDAQ:NNOX

Profound Medical NASDAQ:PROF

Neuronetics NASDAQ:STIM

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools